Back to Search Start Over

Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy.

Authors :
D'Addona M
Pezzullo L
Giudice V
Serio B
Baldi C
Zeppa P
Selleri C
Source :
Clinical case reports [Clin Case Rep] 2022 Jun 05; Vol. 10 (6), pp. e05919. Date of Electronic Publication: 2022 Jun 05 (Print Publication: 2022).
Publication Year :
2022

Abstract

Kaposi's sarcoma is associated with immunosuppression and human herpesvirus 8 infection, while rarely described in myeloid malignancies. Here, we illustrate a rare case of chronic myeloid leukemia treated with imatinib, a tyrosine kinase inhibitor, who developed a human herpesvirus 8-related Kaposi's sarcoma.<br />Competing Interests: The authors declare no conflict of interest.<br /> (© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
2050-0904
Volume :
10
Issue :
6
Database :
MEDLINE
Journal :
Clinical case reports
Publication Type :
Report
Accession number :
35677856
Full Text :
https://doi.org/10.1002/ccr3.5919